Renal Cell Carcinoma (RCC)

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Renal Cell Carcinoma (RCC)
May 28, 2025, 05:38 | Drugs
Sorafenib (Nexavar): What patients need to know?
Sorafenib is a targeted cancer treatment taken as a tablet. It has been approved by…
May 24, 2025, 12:20 | Drugs
Sorafenib (Nexavar): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Sorafenib is a targeted oral cancer therapy that works by disrupting the growth signals cancer…
Apr 30, 2025, 07:31 | Drugs
Cabozantinib: Uses in Cancer, Side effects, Dosage, Expectation, and more
Cabozantinib is an oral tyrosine kinase inhibitor used to treat various cancers. It targets multiple…
Oct 29, 2024, 21:00 | Positive
Steven O'Day: At the Forefront of Immunotherapy
Dr. Steven O'Day, an immunotherapy pioneer and medical oncologist, is the Chief Medical Officer at…
Jul 27, 2024, 11:35 | Blog
Daniel Shapiro: Pleased to present our thoughts on the current adjuvant trials for RCC
Daniel Shapiro, Urologic Oncologist at UW Urology, shared a post on X about his recent…
Jul 15, 2024, 08:57 | Blog
Yüksel Ürün: Prognostic and predictive biomarkers in RCC by Payal Kapur
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X: “ Outstanding presentation at…
Jan 18, 2024, 15:12 | Blog
Maria Natalia Gandur Quiroga: Immuno-Oncology Advances in Genitourinary Cancers
Maria Natalia Gandur Quiroga shared a post on LinkedIn: "Immuno-Oncology Advances in Genitourinary Cancers: Introduction:…
Dec 18, 2023, 21:06 | Insight
Toni Choueiri: A new option for our Kidney Cancer patients!
Toni Choueiri shared on LinkedIn: "JUST IN: FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell…
All: 8 Posts: 1 - 100
Special Coverage